Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-30 12:10:25 - browse：244

The Food and Drug Administration on Friday approved a new, rapid-acting medicine made by Sage Therapeutics to treat postpartum depression, the first oral treatment for the condition. But the agency denied the company’s application for an indication for major depression, a much larger potential market.

The drug, which will be sold under the brand name Zurzuvae, is not meant to be taken chronically. Patients take it orally for 14 days. In two clinical trials, the drug was found to significantly improve depressive symptoms more than a placebo. The effect was maintained for four weeks after treatment.

“Maternal mental health has been sidelined for far too long, but today’s approval of Zurzuvae helps to change that. Women have been waiting for an oral medicine that can specifically and rapidly improve the symptoms of PPD and we are proud to be able to deliver that,” said Barry Greene, Sage’s CEO, in a press release.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

focus

WSS

Anthony Fauci pushes back on GOP claims during Covid hearing

STAT wants to know your pick for a great summer read or listen

A new initiative will help leaders fight the next pandemic

Patients' immediate access to test results puts radiologists in a bind

Patients' immediate access to test results puts radiologists in a bind

UnitedHealth CEO's Medicaid comments send insurer stocks diving

leisure time

Wikipedia

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

Teach medical students about patients with intellectual disabilities

Hepatitis C has a cure — but many Americans still lack access to it

Illumina board agrees to spin off Grail, as divestment plans proceed

Drug repurposing or repositioning? The language matters

Illumina board agrees to spin off Grail, as divestment plans proceed

Medical leaders decry Supreme Court decision on affirmative action

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

DIEP, the 'gold standard' of breast reconstruction, is under threat

Take antibiotics after sex, CDC recommends for certain risk groups

entertainment

A new initiative will help leaders fight the next pandemic

'Little Tech' descents on D.C., wanting a say in how AI is regulated

Structure Therapeutics oral GLP

In diabetes hearing, Sanders takes on a new foe: food makers

What PEPFAR has meant on the ground in Ukraine

STAT letters to the editor on burnt

focus

focus

knowledge

hotspot